Lisa Wyman

Lisa Wyman has served as Chief Technical and Quality Officer at Scholar Rock since 2025. Most recently, Lisa served as Chief Technical Operations Officer and Chief Digital Officer at Generate:Biomedicines, where she managed diverse teams in CMC, technical development, IT, quality, and supply operations.. Previously, she was the Senior Vice President of Technical Operations and Quality at Acceleron, where she played a key role in transforming the company from a research-focused entity to a fully integrated biotech firm, culminating in its sale to Merck & Co. for over $11 billion in 2021. Lisa spearheaded the CMC strategy for the development of WinRevair (Sotatercept) for pulmonary arterial hypertension and aided in the launch of Acceleron's first commercial product, Reblozyl®. She has extensive experience with global regulatory bodies, GxP quality management systems, and scaling up manufacturing for clinical-stage companies. Her prior experience includes roles at Mersana Therapeutics, Shire, and Boston Scientific. Lisa is an industry leader, recognized with awards such as the Life Sciences Voice Top Industry Leader, Boston Business Journal’s 40 Under 40, and Control and Plant Engineering Magazine’s Engineering Leader. Lisa graduated from Ithaca College with a BS in Biology and earned her MS in Engineering Management from Tufts University.